Occurrence of a USA300 vancomycin-intermediate Staphylococcus aureus

被引：25
作者：
Hageman, Jeffrey C. [1 ]
Patel, Jean [1 ]
Franklin, Patrick [2 ]
Miscavish, Karen [3 ]
McDougal, Linda [1 ]
Lonsway, David [1 ]
Khan, Fazle N. [2 ]
机构：
[1] Ctr Dis Control & Prevent, Atlanta, GA 30033 USA
[2] Missouri Dept Hlth & Senior Serv, Jefferson City, MO USA
[3] Kansas City Hlth Dept, Kansas City, MO USA
来源：
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2008年 / 62卷 / 04期
关键词：
Staphylococcus aureus; Vancomycin; VISA;
D O I：
10.1016/j.diagmicrobio.2008.08.005
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
A vancomycin-intermediate Staphylococcus aureus (VISA) isolated from the blood of a 46-year-old patient with endocarditis was determined to be pulsed-field type USA300, daptomycin nonsusceptible, and positive for the Panton-Valentine leukocidin genes. Development of the VISA phenotype does not appear limited to traditional health care strains of S. aureus. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码：440 / 442
页数：3
相关论文
共 12 条
[1]  
*CLIN LAB STAND I, M7A7 CLSI NCCLS
[2]  
*CLIN LAB STAND I, 2006, M100S16 CLSI NCCLS
[3]   Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus [J].
Cui, L ;
Ma, XX ;
Sato, K ;
Okuma, K ;
Tenover, FC ;
Mamizuka, EM ;
Gemmell, CG ;
Kim, MN ;
Ploy, MC ;
El Solh, N ;
Ferraz, V ;
Hiramatsu, K .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (01) :5-14
[4]   Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001 [J].
Fridkin, SK ;
Hageman, J ;
McDougal, LK ;
Mohammed, J ;
Jarvis, WR ;
Perl, TM ;
Tenover, FC .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (04) :429-439
[5]   Intermediate vancomycin susceptibility in a community-associated MRSA clone [J].
Graber, Christopher J. ;
Wong, Margaret K. ;
Carleton, Heather A. ;
Perdreau-Remington, Francoise ;
Haller, Barbara L. ;
Chambers, Henry F. .
EMERGING INFECTIOUS DISEASES, 2007, 13 (03) :491-493
[6]   Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility [J].
Hiramatsu, K ;
Hanaki, H ;
Ino, T ;
Yabuta, K ;
Oguri, T ;
Tenover, FC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (01) :135-136
[7]   Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains [J].
Ma, XX ;
Ito, T ;
Tiensasitorn, C ;
Jamklang, M ;
Chongtrakool, P ;
Boyle-Vavra, S ;
Daum, RS ;
Hiramatsu, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (04) :1147-1152
[8]   Development of decreased susceptibility to daptomycin and vancomycin in a Staphylococcus aureus strain during prolonged therapy [J].
Mariani, Paul G. ;
Sader, Helio S. ;
Jones, Ronald N. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (02) :481-483
[9]   Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States:: Establishing a national database [J].
McDougal, LK ;
Steward, CD ;
Killgore, GE ;
Chaitram, JM ;
McAllister, SK ;
Tenover, FC .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (11) :5113-5120
[10]   Methicillin-resistant S-aureus infections among patients in the emergency department [J].
Moran, Gregory J. ;
Krishnadasan, Anusha ;
Gorwitz, Rachel J. ;
Fosheim, Gregory E. ;
McDougal, Linda K. ;
Carey, Roberta B. ;
Talan, David A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (07) :666-674
12